250 related articles for article (PubMed ID: 1099964)
1. Activation of the complement and properdin systems in rheumatoid arthritis.
Ruddy S; Austen KF
Ann N Y Acad Sci; 1975 Jun; 256():96-104. PubMed ID: 1099964
[TBL] [Abstract][Full Text] [Related]
2. Correlation between levels of breakdown products of C3, C4, and properdin factor B in synovial fluids from patients with rheumatoid arthritis.
Perrin LH; Nydegger UE; Zubler RH; Lambert PH; Miescher PA
Arthritis Rheum; 1977 Mar; 20(2):647-52. PubMed ID: 849359
[TBL] [Abstract][Full Text] [Related]
3. The properdin pathway: mechanisms of complement activation and analogies to the classical pathway.
Fearon DT; Austen KF; Ruddy S
Rheumatology; 1975; 6():2-16. PubMed ID: 1105744
[No Abstract] [Full Text] [Related]
4. C3b inactivator in the rheumatic diseases. Measurement by radial immunodiffusion and by inhibition of formation of properdin pathway C3 convertase.
Whaley K; Schur PH; Ruddy S
J Clin Invest; 1976 Jun; 57(6):1554-63. PubMed ID: 819459
[TBL] [Abstract][Full Text] [Related]
5. [The complement system].
Lambert PH
Schweiz Med Wochenschr; 1975 Sep; 105(37):1180-4. PubMed ID: 1215899
[TBL] [Abstract][Full Text] [Related]
6. Depressed synovial fluid levels of properdin and properdin factor B in patients with rheumatoid arthritis.
Ruddy S; Fearon DT; Austen KF
Arthritis Rheum; 1975; 18(4):289-95. PubMed ID: 808229
[TBL] [Abstract][Full Text] [Related]
7. [Complement activation and biological activities].
Inoue K
Nihon Saikingaku Zasshi; 1976 Jul; 31(4):535-55. PubMed ID: 988219
[No Abstract] [Full Text] [Related]
8. Clinical applications of complement measurements in rheumatic diseases.
Goldstein IM
Am J Med Sci; 1975; 269(2):172-82. PubMed ID: 1096603
[TBL] [Abstract][Full Text] [Related]
9. Activation of complement components C3 and factor B in synovial fluids.
Hunder GG; McDuffie FC; Mullen BJ
J Lab Clin Med; 1977 Jan; 89(1):160-71. PubMed ID: 830776
[TBL] [Abstract][Full Text] [Related]
10. Complement fixation by solid phase immune complexes. Reduced capacity in SLE sera.
Baatrup G; Jonsson H; Sjöholm A; Sturfelt G; Svehag SE
J Clin Lab Immunol; 1988 Jun; 26(2):73-9. PubMed ID: 3264027
[TBL] [Abstract][Full Text] [Related]
11. Schistosoma mansoni: the role of the complement C3-activating system in the cercaricidal action of normal serum.
Machado AJ; Gazzinelli G; Pellegrino J; Dias de Silva W
Exp Parasitol; 1975 Aug; 38(1):20-9. PubMed ID: 807484
[No Abstract] [Full Text] [Related]
12. Clearances of complement components, C3 proactivator and other serum proteins in chronic membranoproliferative glomerulonephritis (CMPGN).
Geiger H; Good RA; Day NK
Clin Nephrol; 1975; 3(4):139-47. PubMed ID: 1149337
[TBL] [Abstract][Full Text] [Related]
13. Increased biosynthesis of complement components by cultured monocytes, synovial fluid macrophages and skynovial membrane cells from patients with rheumatoid arthritis.
de Ceulaer C; Papazoglou S; Whaley K
Immunology; 1980 Sep; 41(1):37-43. PubMed ID: 6903558
[TBL] [Abstract][Full Text] [Related]
14. Activation of the complement system by antibody-antigen complexes: the classical pathway.
Porter RR; Reid KB
Adv Protein Chem; 1979; 33():1-71. PubMed ID: 396780
[No Abstract] [Full Text] [Related]
15. Altered local metabolism of complement components in rheumatoid arthritis.
Ruddy S
Rheumatology; 1975; 6():17-23. PubMed ID: 1105743
[No Abstract] [Full Text] [Related]
16. The proteolytic activation systems of complement.
Reid KB; Porter RR
Annu Rev Biochem; 1981; 50():433-64. PubMed ID: 7023363
[No Abstract] [Full Text] [Related]
17. Surface modulation of classical pathway activation: C2 and C3 convertase formation and regulation on sheep, guinea pig, and human erythrocytes.
Brown EJ; Ramsey J; Hammer CH; Frank MM
J Immunol; 1983 Jul; 131(1):403-8. PubMed ID: 6602833
[TBL] [Abstract][Full Text] [Related]
18. Alternative pathway of complement: recruitment of precursor properdin by the labile C3/C5 convertase and the potentiation of the pathway.
Medicus RG; Götze O; Müller-Eberhard HJ
J Exp Med; 1976 Oct; 144(4):1076-93. PubMed ID: 978134
[TBL] [Abstract][Full Text] [Related]
19. Complement activation in seropositive and seronegative rheumatoid arthritis. 125I-C1q binding capacity and complement breakdown products in serum and synovial fluid.
Lambert PH; Nydegger UE; Perrin LH; McCormic J; Fehr K; Miescher PA
Rheumatology; 1975; 6():52-9. PubMed ID: 1202608
[TBL] [Abstract][Full Text] [Related]
20. Function of the classical and alternate pathways of human complement in serum treated with ethylene glycol tetraacetic acid and MgCl2-ethylene glycol tetraacetic acid.
Des Prez RM; Bryan CS; Hawiger J; Colley DG
Infect Immun; 1975 Jun; 11(6):1235-43. PubMed ID: 806523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
